JP2001521039A - ２−ハロ−６−ｏ−置換ケトライド誘導体 - Google Patents

２−ハロ−６−ｏ−置換ケトライド誘導体

Info

Publication number
JP2001521039A
JP2001521039A JP2000517980A JP2000517980A JP2001521039A JP 2001521039 A JP2001521039 A JP 2001521039A JP 2000517980 A JP2000517980 A JP 2000517980A JP 2000517980 A JP2000517980 A JP 2000517980A JP 2001521039 A JP2001521039 A JP 2001521039A
Authority
JP
Japan
Prior art keywords
compound
formula
quinolinyl
substituted
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000517980A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001521039A5 (enExample
Inventor
フアン，リー・タン
オア，ヤツト・サン
チユー，ダニエル・テイー
プラツトナー，ジエイコブ・ジエイ
チエン，ヤン
クラーク，リチヤード・エフ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of JP2001521039A publication Critical patent/JP2001521039A/ja
Publication of JP2001521039A5 publication Critical patent/JP2001521039A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
JP2000517980A 1997-10-29 1998-10-29 ２−ハロ−６−ｏ−置換ケトライド誘導体 Pending JP2001521039A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US95988197A 1997-10-29 1997-10-29
US08/959,881 1997-10-29
US15423998A 1998-09-16 1998-09-16
US09/154,239 1998-09-16
PCT/US1998/022989 WO1999021871A1 (en) 1997-10-29 1998-10-29 2-halo-6-o-substituted ketolide derivatives

Publications (2)

Publication Number Publication Date
JP2001521039A true JP2001521039A (ja) 2001-11-06
JP2001521039A5 JP2001521039A5 (enExample) 2006-01-05

Family

ID=26851273

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000517980A Pending JP2001521039A (ja) 1997-10-29 1998-10-29 ２−ハロ−６−ｏ−置換ケトライド誘導体

Country Status (24)

Country Link
EP (1) EP1027362B1 (enExample)
JP (1) JP2001521039A (enExample)
KR (1) KR100536420B1 (enExample)
CN (1) CN1240707C (enExample)
AR (1) AR015994A1 (enExample)
AT (1) ATE298760T1 (enExample)
AU (1) AU751448B2 (enExample)
BG (1) BG64707B1 (enExample)
BR (1) BR9813319A (enExample)
CA (1) CA2307788C (enExample)
CO (1) CO4990960A1 (enExample)
CZ (1) CZ300063B6 (enExample)
DE (1) DE69830739T2 (enExample)
DK (1) DK1027362T3 (enExample)
ES (1) ES2244094T3 (enExample)
HU (1) HUP0004282A3 (enExample)
IL (1) IL135519A0 (enExample)
NO (1) NO20002190L (enExample)
NZ (1) NZ503822A (enExample)
PL (1) PL191453B1 (enExample)
PT (1) PT1027362E (enExample)
SK (1) SK286397B6 (enExample)
TR (1) TR200001142T2 (enExample)
WO (1) WO1999021871A1 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523938A (ja) * 1999-04-16 2003-08-12 コーサン バイオサイエンシーズ， インコーポレイテッド マクロライド系抗感染剤
WO2004078771A1 (ja) * 2003-03-07 2004-09-16 Taisho Pharmaceutical Co., Ltd. ２－フルオロ－６－ｏ－置換ケトライド誘導体
JP2005522453A (ja) * 2002-02-13 2005-07-28 アボット・ラボラトリーズ マクロライド抗菌化合物
WO2005087787A1 (ja) * 2004-03-16 2005-09-22 Taisho Pharmaceutical Co., Ltd. ２−フルオロ−６−ｏ−置換ケトライド誘導体

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39743E1 (en) * 1998-10-15 2007-07-24 Aventis Pharma S.A. 2-halogenated derivatives of 5-0 desosaminyl-erythronolide a, their preparation process and their antibiotic use
FR2784682B1 (fr) * 1998-10-15 2002-12-06 Hoechst Marion Roussel Inc Nouveaux derives 2-halogene de 5-0-desosaminylerythronolide a, leur procede de preparation et leur application comme medicaments
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6569836B2 (en) 1999-12-02 2003-05-27 Abbott Laboratories 6-O-alkyl-2-nor-2-substituted ketolide derivatives
JP2003527347A (ja) * 1999-12-02 2003-09-16 アボット・ラボラトリーズ ６−ｏ−アルキル−２−ノル−２−置換ケトリド誘導体
JP2001261694A (ja) * 2000-03-06 2001-09-26 Pfizer Prod Inc ケトライド抗生物質
US6605707B1 (en) 2000-03-23 2003-08-12 Abbott Laboratories Process for the preparation of 6-O-propargyl erythromycin derivatives
PT1167376E (pt) 2000-06-30 2004-09-30 Pfizer Prod Inc Antibioticos macrolidos
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
CA2460947A1 (en) 2001-09-17 2003-03-27 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
RU2004117082A (ru) 2001-12-05 2005-04-10 Орто-Макнейл Фармасьютикал, Инк. (Us) Кетолидные 6-0-ацил-производные эритромицина в качестве антибактериальных средств
CA2483220A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories Oxolide antibacterials
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
MX2011012614A (es) * 2009-05-27 2012-02-22 Wockhardt Ltd Compuestos de quetolida que tienen actividad antimicrobiana.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61251696A (ja) * 1985-03-12 1986-11-08 ビ−チヤム・グル−プ・ピ−エルシ− 新規化合物，その製法及びそれを含む医薬組成物
WO1993021199A1 (fr) * 1992-04-22 1993-10-28 Taisho Pharmaceutical Co., Ltd. Derive de 5-o-desosaminylerythronolide
JPH09176182A (ja) * 1995-12-22 1997-07-08 Roussel Uclaf 新規なエリスロマイシン、それらの製造法及び薬剤としての用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61251696A (ja) * 1985-03-12 1986-11-08 ビ−チヤム・グル−プ・ピ−エルシ− 新規化合物，その製法及びそれを含む医薬組成物
WO1993021199A1 (fr) * 1992-04-22 1993-10-28 Taisho Pharmaceutical Co., Ltd. Derive de 5-o-desosaminylerythronolide
WO1993021200A1 (en) * 1992-04-22 1993-10-28 Taisho Pharmaceutical Co., Ltd. 5-o-desosaminylerythronolide a derivative
JPH09176182A (ja) * 1995-12-22 1997-07-08 Roussel Uclaf 新規なエリスロマイシン、それらの製造法及び薬剤としての用途

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523938A (ja) * 1999-04-16 2003-08-12 コーサン バイオサイエンシーズ， インコーポレイテッド マクロライド系抗感染剤
JP2005522453A (ja) * 2002-02-13 2005-07-28 アボット・ラボラトリーズ マクロライド抗菌化合物
WO2004078771A1 (ja) * 2003-03-07 2004-09-16 Taisho Pharmaceutical Co., Ltd. ２－フルオロ－６－ｏ－置換ケトライド誘導体
WO2005087787A1 (ja) * 2004-03-16 2005-09-22 Taisho Pharmaceutical Co., Ltd. ２−フルオロ−６−ｏ−置換ケトライド誘導体

Also Published As

Publication number Publication date
KR20010015793A (ko) 2001-02-26
CN1283199A (zh) 2001-02-07
DE69830739T2 (de) 2006-04-20
EP1027362B1 (en) 2005-06-29
PL191453B1 (pl) 2006-05-31
DK1027362T3 (da) 2005-10-31
CA2307788C (en) 2008-05-20
ATE298760T1 (de) 2005-07-15
PL340290A1 (en) 2001-01-29
SK6332000A3 (en) 2000-09-12
CN1240707C (zh) 2006-02-08
HK1031383A1 (en) 2001-06-15
HUP0004282A3 (en) 2001-10-29
AU751448B2 (en) 2002-08-15
ES2244094T3 (es) 2005-12-01
DE69830739D1 (de) 2005-08-04
NZ503822A (en) 2002-12-20
SK286397B6 (sk) 2008-09-05
CO4990960A1 (es) 2000-12-26
CZ20001525A3 (cs) 2000-10-11
PT1027362E (pt) 2005-08-31
BG64707B1 (bg) 2005-12-30
EP1027362A1 (en) 2000-08-16
AU1288199A (en) 1999-05-17
CZ300063B6 (cs) 2009-01-21
KR100536420B1 (ko) 2005-12-16
NO20002190D0 (no) 2000-04-27
WO1999021871A1 (en) 1999-05-06
IL135519A0 (en) 2001-05-20
BR9813319A (pt) 2000-08-22
BG104434A (en) 2001-01-31
AR015994A1 (es) 2001-05-30
HUP0004282A2 (hu) 2001-04-28
TR200001142T2 (tr) 2000-09-21
CA2307788A1 (en) 1999-05-06
NO20002190L (no) 2000-06-29

Similar Documents

Publication Publication Date Title
US6124269A (en) 2-Halo-6-O-substituted ketolide derivatives
JP2001521039A (ja) ２−ハロ−６−ｏ−置換ケトライド誘導体
US5922683A (en) Multicyclic erythromycin derivatives
EP1161438B1 (en) 6-o-substituted macrolides having antibacterial activity
CA2301643A1 (en) 6,9-bridged erythromycin derivatives
JP2001521038A (ja) ６，１１−架橋エリスロマイシン誘導体
US6034069A (en) 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
US6946446B2 (en) Anti-infective agents useful against multidrug-resistant strains of bacteria
US5780604A (en) 11,12-cyclic phosphite or phosphate derivatives of erythromycin and related macrolides
US6569836B2 (en) 6-O-alkyl-2-nor-2-substituted ketolide derivatives
CA2391297C (en) 6-o-alkyl-2-nor-2-substituted ketolide derivatives
JP4025548B2 (ja) 多薬剤耐性菌株に対して有用な抗感染症薬
EP0984975B1 (en) Multicyclic erythromycin derivatives
HK1031383B (en) 2-halo-6-o-subsituted ketolide derivatives
MXPA00004226A (es) Derivados de ketólido 2-halo-6-o-substituidos

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051027

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051027

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090804

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091028

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091105

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100203

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100525

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101026